Navigation Links
Cystinosis Research Network Unveils New Communication Strategy and Website
Date:1/29/2009

Cystinosis Research Network, a non-profit organization funding research for the genetic disorder cystinosis, unveils new communication strategy and website.

Lake Forest, IL (PRWEB) January 29, 2009 -- The Cystinosis Research Network, a non-profit organization aimed at supporting and funding research for the rare genetic disorder cystinosis, has launched a new brand and enhanced website at www.cystinosis.org. The project included the creation of a new logo and tagline, website design and development, and the creation of an e-mail marketing strategy which will improve the organization's efficacy as the voice of the cystinosis community.

President and Executive Director Christy Greeley said CRN is the only cystinosis support organization which provides the full breadth of support activities so vital to its community: Research, Education and Family Support. "The new website design and the new logo and motto, "Dedicated to a Cure. Committed to our Community" showcase CRN's vision and mission to the world". CRN partnered with Altos Marketing Group to strengthen its communication strategy and to develop the new branding and website. The communication strategy emphasizes the organization's unique position as a resource for families and researchers. CRN's new logo, two interlocking puzzle pieces, was designed to represent the importance of collaboration between the cystinosis and the research community coming together to develop a cure for the disease.

The new website, launched on January 7, includes a wealth of information for doctors and for people diagnosed with cystinosis, including comprehensive studies, medical resources, and access to support groups. CRN and Altos staff collaborated to reorganize the site's content into a user-friendly and visually appealing format. The new website also incorporates secure on-line donation and shopping functionality. Altos also engaged in the development of a new CRN email marketing solution. The email solution will enable CRN to communicate more effectively about research developments, grant opportunities, special events, and volunteer openings.

"CRN is proud of all of the advancements achieved by partnering with Altos Marketing Group. We feel fortunate to have benefited from their design expertise, cutting-edge technology, and tremendous follow-through," says Paula Shal, Vice President, Education and Awareness.

About the Cystinosis Research Network
The Cystinosis Research Network is a volunteer, non-profit organization dedicated to supporting and advocating research, providing family assistance and educating the public and medical communities about cystinosis. Visit us at Cystinosis Research Network.

About Altos Marketing Group
Headquartered in Bedford, NH, Altos Marketing Group is a full-service branding, marketing and web development firm offering advertising, design, marketing strategy, web development and planning to a diverse base of regional and national clients. Visit us at Altos Marketing Group.

###

Read the full story at http://www.prweb.com/releases/2009/01/prweb1928244.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Medical College of Wisconsin recognized for AIDS intervention research
2. Glaucoma Research Foundation to Hold Annual Fundraising Benefit
3. UNT Health Science Center Researchers Discover Eating Less May Not Increase Life Expectancy
4. Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies
5. Statement on Comparative Effectiveness Research Under Senate Appropriations Committee Stimulus Bill
6. Lung Cancer Alliance Hails Early Introduction of Comprehensive Lung Cancer Research Legislation
7. Summer Street Research Partners Closes Two More Healthcare Company Financings
8. Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
9. UTSA receives federal funding for fossil fuel research
10. 1.2 Million Dollars Recently Awarded to Institute for Myeloma and Bone Cancer Research
11. Center for Healthcare Research & Transformation Releases Cover Michigan - a Report on Healthcare Coverage and Access
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Y. (PRWEB) , ... February 27, 2017 , ... POUGHKEEPSIE, ... ILADS ) has disclosed that despite scientific studies, the Center for Disease Control ( ... chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into a single ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... scheduling, and reporting for healthcare organizations. This comprehensive and customizable solution empowers ... process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects critical reporting ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ability to ... Studios. With ProSharpen Color users have total control over sharpening amount, sharpening radius, threshold, ... With color spectrum tools users can visually see the color range effected with ease ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  Interpace Diagnostics Group, ... provides clinically useful molecular diagnostic tests and pathology services, ... presented at the upcoming United States ... held March 4-10, 2017 in San Antonio, ... a review of data from the Company,s extensive experience ...
(Date:2/27/2017)... Fla. , Feb. 27, 2017 ... focused on developing cerebral embolic protection devices for ... the FDA,s Circulatory System Devices Panel that convened ... need for cerebral protection following transcatheter aortic valve ... by this FDA panel support the need for ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
Breaking Medicine Technology: